HSBC Holdings’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
HSBC Holdings's MXCT Position: Q1 2026 in Review
HSBC Holdings reduced its MaxCyte (MXCT) stake by 15% in Q1 2026, selling an estimated $42.2K and leaving 250,172 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #2646.
HSBC Holdings first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.25M in Q3 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- HSBC Holdings held 250,172 shares of MaxCyte worth $172K as of Q1 2026.
- HSBC Holdings sold 45,228 MaxCyte shares in Q1 2026, an estimated $42.2K.
- MaxCyte made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2646 holding.
- HSBC Holdings first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
- HSBC Holdings's MaxCyte position peaked at $1.25M in Q3 2021.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.